mRNA |
Bicalutamide |
GDSC1000 |
pan-cancer |
AAC |
0.007 |
0.8 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0065 |
0.8 |
mRNA |
CBB-1007 |
CTRPv2 |
pan-cancer |
AAC |
-0.011 |
0.8 |
mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0071 |
0.8 |
mRNA |
dinaciclib |
CTRPv2 |
pan-cancer |
AAC |
-0.0099 |
0.8 |
mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0069 |
0.8 |
mRNA |
Zebularine |
CTRPv2 |
pan-cancer |
AAC |
-0.0069 |
0.8 |
mRNA |
KU-60019 |
CTRPv2 |
pan-cancer |
AAC |
-0.007 |
0.8 |
mRNA |
Camptothecin |
GDSC1000 |
pan-cancer |
AAC |
0.0068 |
0.8 |
mRNA |
lenalidomide |
FIMM |
pan-cancer |
AAC |
-0.034 |
0.8 |